Correlation Between Genelux Common and NGM Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Genelux Common and NGM Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and NGM Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genelux Common and NGM Biopharmaceuticals, you can compare the effects of market volatilities on Genelux Common and NGM Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of NGM Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and NGM Biopharmaceutica.
Diversification Opportunities for Genelux Common and NGM Biopharmaceutica
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genelux and NGM is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and NGM Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NGM Biopharmaceuticals and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with NGM Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NGM Biopharmaceuticals has no effect on the direction of Genelux Common i.e., Genelux Common and NGM Biopharmaceutica go up and down completely randomly.
Pair Corralation between Genelux Common and NGM Biopharmaceutica
If you would invest 250.00 in NGM Biopharmaceuticals on September 12, 2024 and sell it today you would earn a total of 0.00 from holding NGM Biopharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.3% |
| Values | Daily Returns |
Genelux Common vs. NGM Biopharmaceuticals
Performance |
| Timeline |
| Genelux Common |
| NGM Biopharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Genelux Common and NGM Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genelux Common and NGM Biopharmaceutica
The main advantage of trading using opposite Genelux Common and NGM Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, NGM Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NGM Biopharmaceutica will offset losses from the drop in NGM Biopharmaceutica's long position.| Genelux Common vs. Equillium | Genelux Common vs. DiaMedica Therapeutics | Genelux Common vs. Valneva SE ADR | Genelux Common vs. Vivani Medical |
| NGM Biopharmaceutica vs. Instil Bio | NGM Biopharmaceutica vs. Achilles Therapeutics PLC | NGM Biopharmaceutica vs. NextCure | NGM Biopharmaceutica vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |